BioPharma Media

* Pancreatic cancer is a highly challenging oncologic disease to treat.
* Only 20% of patients are eligible for surgical tumor resection.
* Even if tumors are successfully removed, they almost always recur, leading to rapid death.
* A personalized cancer vaccine, autogene cevumeran by and of , has been shown to delay recurrence and death by three years in one-third of patients.
* However, the availability and cost of this breakthrough therapy remain open questions.

Autogene Cevumeran: Powerful mRNA Vaccine Against Pancreatic Cancer • BioPharma Media Personalized immunotherapy prolonged life in one-third of patients with pancreatic ductal adenocarcinoma.

by Pharma is a nice addition to the existing armamentarium of hypotensive drugs, which has not been updated for many years.

Adding baxdrostat to the usual cardiology drugs solves the problem of high blood pressure in resistant or uncontrolled .

Baxdrostat: New Treatment for Resistant Hypertension • BioPharma Media A selective aldosterone synthase inhibitor for significantly lowering blood pressure.